Nektar Therapeutics (NKTR) Net income 2016–2025
Nektar Therapeutics (NKTR) annual net income history from SEC filings — each fiscal year as reported, with year-over-year change.
-$164.1MFY2025 · since FY2016: -$153.5M → -$164.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$164.1M | -37.9% |
| FY2024 | -$119.0M | +56.9% |
| FY2023 | -$276.1M | +25.0% |
| FY2022 | -$368.2M | +29.7% |
| FY2021 | -$523.8M | -17.9% |
| FY2020 | -$444.4M | -0.9% |
| FY2019 | -$440.7M | -164.7% |
| FY2018 | $681.3M | +804.6% |
| FY2017 | -$96.7M | +37.0% |
| FY2016 | -$153.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice